Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation

Int J Mol Sci. 2017 Apr 26;18(5):908. doi: 10.3390/ijms18050908.

Abstract

Colorectal cancer is a major healthcare concern worldwide. Many experimental and clinical studies have been conducted to date to discover agents that help in the prevention of this disease. Chronic inflammation in colonic mucosa and obesity, and its related metabolic abnormalities, are considered to increase the risk of colorectal cancer. Therefore, treatments targeting these factors might be a promising strategy to prevent the development of colorectal cancer. Among a number of functional foods, various phytochemicals, including tea catechins, which have anti-inflammatory and anti-obesity properties, and medicinal agents that ameliorate metabolic disorders, might also be beneficial in the prevention of colorectal cancer. In this review article, we summarize the strategies for preventing colorectal cancer by targeting obesity-related disorders and inflammation through nutraceutical and pharmaceutical approaches, and discuss the mechanisms of several phytochemicals and medicinal drugs used in basic and clinical research, especially focusing on the effects of green tea catechins.

Keywords: chemoprevention; colorectal cancer; green tea; inflammation; obesity.

Publication types

  • Review

MeSH terms

  • Animals
  • Catechin / analogs & derivatives
  • Catechin / chemistry
  • Catechin / metabolism
  • Catechin / therapeutic use
  • Colorectal Neoplasms / pathology
  • Colorectal Neoplasms / prevention & control*
  • Humans
  • Inflammation* / prevention & control
  • Obesity / drug therapy*
  • Phytochemicals / therapeutic use*
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Tea / chemistry
  • Tea / metabolism

Substances

  • Phytochemicals
  • Tea
  • Catechin
  • epigallocatechin gallate
  • Receptor Protein-Tyrosine Kinases